➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Colorcon
Merck
AstraZeneca
Harvard Business School

Last Updated: June 24, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Nemonoxacin


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Nemonoxacin?

Nemonoxacin is an investigational drug.

There have been 12 clinical trials for Nemonoxacin. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2011.

The most common disease conditions in clinical trials are Pneumonia, Communicable Diseases, and Pneumonia, Bacterial. The leading clinical trial sponsors are TaiGen Biotechnology Co., Ltd., Zhejiang Medicine Co., Ltd., and Huashan Hospital.

Recent Clinical Trials for Nemonoxacin
TitleSponsorPhase
Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Severe Impaired Renal FunctionZhejiang Medicine Co., Ltd.Phase 1
An International, Multicenter, Randomized, Double-blind, Double-dummy, Two-way, Parallel Group, Controlled Study to Compare the Efficacy and Safety of Intravenous and Oral Nemonoxacin Versus Tavanic® in Adult Patients With Community-acquired PneumoOCT Clinical TrialsPhase 3
An International, Multicenter, Randomized, Double-blind, Double-dummy, Two-way, Parallel Group, Controlled Study to Compare the Efficacy and Safety of Intravenous and Oral Nemonoxacin Versus Tavanic® in Adult Patients With Community-acquired PneumoR-PharmPhase 3

See all Nemonoxacin clinical trials

Clinical Trial Summary for Nemonoxacin

Top disease conditions for Nemonoxacin
Top clinical trial sponsors for Nemonoxacin

See all Nemonoxacin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Merck
Colorcon
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.